| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |